Precision Health Clinical Trials
Protocols Development for Single Cells Genomics and Their Implementation for Molecular Diversity Between Cells
Condition: Healthy
Intervention: Other: non
Sponsor: Hadassah Medical Organization
Not yet recruiting
Intervention: Other: non
Sponsor: Hadassah Medical Organization
Not yet recruiting
For more information, visit the Study URL.
Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene
Condition: Spinal Muscular Atrophy
Intervention: Procedure: blood sampling
Sponsors: University Hospital, Rouen; Society GENOMIC VISION
Recruiting
Intervention: Procedure: blood sampling
Sponsors: University Hospital, Rouen; Society GENOMIC VISION
Recruiting
For more information, visit the Study URL.
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
Conditions: Amyloidosis; Primary Amyloidosis
Intervention:
Sponsor: Tufts Medical Center
Recruiting
Intervention:
Sponsor: Tufts Medical Center
Recruiting
For more information, visit the Study URL.
5-HT3 Antagonists (Antiemetics) and Cardiac Safety
Condition: Adverse Reaction to Other Drugs and Medicines
Intervention: Drug: Ondansetron
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting
Intervention: Drug: Ondansetron
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting
For more information, visit the Study URL.
The Vanderbilt Atrial Fibrillation Ablation Registry
Condition: Atrial Fibrillation
Intervention:
Sponsor: Vanderbilt University
Recruiting
Intervention:
Sponsor: Vanderbilt University
Recruiting
For more information, visit the Study URL.
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.
Condition: Malignant Neoplasm
Interventions: Drug: ponatinib hydrochloride; Other: laboratory biomarker analysis
Sponsor: Sameek Roychowdhury
Recruiting
Interventions: Drug: ponatinib hydrochloride; Other: laboratory biomarker analysis
Sponsor: Sameek Roychowdhury
Recruiting
For more information, visit the Study URL.
Cerebellar Mutism Syndrome Study
Conditions: Infratentorial Neoplasms; Mutism
Intervention:
Sponsors: Rigshospitalet, Denmark; Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital; Technical University of Denmark; Karolinska University Hospital; Skane University Hospital; University Hospital, Linkoeping; Uppsala University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Oslo University Hospital; Trondheim University Hospital; Haukeland University Hospital; University Hospital of North Norway; Helsinki University Central Hospital; Tampere University Hospital; Kuopio University Hospital; Turku University Hospital; Oulu University Hospital; Radboud University Medical Center; Liverpool University Hospitals NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust; Nottingham University Hospitals NHS Trust; University Hospital Birmingham; University Hospitals Bristol and Weston NHS Foundation Trust; Royal Infirmary of Edinburgh; South Glasgow University Hospitals NHS Trust; University Hospital Tuebingen; Medical University of Vienna; Ospedale Pediatrico Bambin Gesù
Recruiting
Intervention:
Sponsors: Rigshospitalet, Denmark; Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital; Technical University of Denmark; Karolinska University Hospital; Skane University Hospital; University Hospital, Linkoeping; Uppsala University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Oslo University Hospital; Trondheim University Hospital; Haukeland University Hospital; University Hospital of North Norway; Helsinki University Central Hospital; Tampere University Hospital; Kuopio University Hospital; Turku University Hospital; Oulu University Hospital; Radboud University Medical Center; Liverpool University Hospitals NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust; Nottingham University Hospitals NHS Trust; University Hospital Birmingham; University Hospitals Bristol and Weston NHS Foundation Trust; Royal Infirmary of Edinburgh; South Glasgow University Hospitals NHS Trust; University Hospital Tuebingen; Medical University of Vienna; Ospedale Pediatrico Bambin Gesù
Recruiting
For more information, visit the Study URL.
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm
Condition: Triple Negative Breast Cancers Without Lymph-node Involvement and Intervention: Procedure: Blood samples of 10 mL
Sponsor: Institut Claudius Regaud
Recruiting
Sponsor: Institut Claudius Regaud
Recruiting
For more information, visit the Study URL.
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Genetic: mutation analysis; Other: cytology specimen collection procedure; Other: laboratory biomarker analysis
Sponsor: Stanford University
Recruiting
Interventions: Genetic: mutation analysis; Other: cytology specimen collection procedure; Other: laboratory biomarker analysis
Sponsor: Stanford University
Recruiting
For more information, visit the Study URL.
Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study
Conditions: Chromosomal Instability; Low Grade Dysplasia Oral Cavity; Loss of Heterozygostiy; Fluorescence In Situ Hybridization
Interventions: Procedure: surgery; Other: follow up
Sponsor: Maastricht University Medical Center
Not yet recruiting
Interventions: Procedure: surgery; Other: follow up
Sponsor: Maastricht University Medical Center
Not yet recruiting
For more information, visit the Study URL.